Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Increased expression of glycinamide ribonucleotide transformylase is associated with a poor prognosis in hepatocellular carcinoma, and it promotes liver cancer cell proliferation.

Cong X, Lu C, Huang X, Yang D, Cui X, Cai J, Lv L, He S, Zhang Y, Ni R.

Hum Pathol. 2014 Jul;45(7):1370-8. doi: 10.1016/j.humpath.2013.11.021. Epub 2014 Feb 28.

PMID:
24830618
2.

Expression of FOXJ1 in hepatocellular carcinoma: correlation with patients' prognosis and tumor cell proliferation.

Chen HW, Huang XD, Li HC, He S, Ni RZ, Chen CH, Peng C, Wu G, Wang GH, Wang YY, Zhao YH, Zhang YX, Shen AG, Wang HM.

Mol Carcinog. 2013 Aug;52(8):647-59. doi: 10.1002/mc.21904. Epub 2012 Apr 4.

PMID:
22488567
3.

Clinicopathologic significance and function of S-phase kinase-associated protein 2 overexpression in hepatocellular carcinoma.

Zhang SH, Qian YM, Liu AW, Cai J, Zhao XL, Wei JJ, Zhu MH.

Hum Pathol. 2012 Jul;43(7):1084-93. doi: 10.1016/j.humpath.2011.08.019. Epub 2011 Dec 26.

PMID:
22204716
4.

GART expression in rat spinal cord after injury and its role in inflammation.

Zhang D, Yue Y, Jiang S, Li A, Guo A, Wu X, Xia X, Cheng H, Zhang J, Tao T, Gu X.

Brain Res. 2014 May 20;1564:41-51. doi: 10.1016/j.brainres.2014.03.044. Epub 2014 Apr 4.

PMID:
24709117
5.

LIM and SH3 protein 1, a promoter of cell proliferation and migration, is a novel independent prognostic indicator in hepatocellular carcinoma.

Wang H, Li W, Jin X, Cui S, Zhao L.

Eur J Cancer. 2013 Mar;49(4):974-83. doi: 10.1016/j.ejca.2012.09.032. Epub 2012 Oct 18.

PMID:
23084841
6.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

7.

Upregulated expression of ubiquitin-conjugating enzyme E2Q1 (UBE2Q1) is associated with enhanced cell proliferation and poor prognosis in human hapatocellular carcinoma.

Chang R, Wei L, Lu Y, Cui X, Lu C, Liu L, Jiang D, Xiong Y, Wang G, Wan C, Qian H.

J Mol Histol. 2015 Feb;46(1):45-56. doi: 10.1007/s10735-014-9596-x. Epub 2014 Oct 14.

PMID:
25311764
8.

Expression features of SOX9 associate with tumor progression and poor prognosis of hepatocellular carcinoma.

Guo X, Xiong L, Sun T, Peng R, Zou L, Zhu H, Zhang J, Li H, Zhao J.

Diagn Pathol. 2012 Apr 19;7:44. doi: 10.1186/1746-1596-7-44.

9.

High expression of trimethylated histone H3 lysine 4 is associated with poor prognosis in hepatocellular carcinoma.

He C, Xu J, Zhang J, Xie D, Ye H, Xiao Z, Cai M, Xu K, Zeng Y, Li H, Wang J.

Hum Pathol. 2012 Sep;43(9):1425-35. doi: 10.1016/j.humpath.2011.11.003. Epub 2012 Mar 9.

PMID:
22406368
10.

Myeloid differentiation factor 88 promotes growth and metastasis of human hepatocellular carcinoma.

Liang B, Chen R, Wang T, Cao L, Liu Y, Yin F, Zhu M, Fan X, Liang Y, Zhang L, Guo Y, Zhao J.

Clin Cancer Res. 2013 Jun 1;19(11):2905-16. doi: 10.1158/1078-0432.CCR-12-1245. Epub 2013 Apr 2.

11.

CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Yang XR, Xu Y, Yu B, Zhou J, Li JC, Qiu SJ, Shi YH, Wang XY, Dai Z, Shi GM, Wu B, Wu LM, Yang GH, Zhang BH, Qin WX, Fan J.

Clin Cancer Res. 2009 Sep 1;15(17):5518-27. doi: 10.1158/1078-0432.CCR-09-0151. Epub 2009 Aug 25.

12.

B7-H3 is expressed in human hepatocellular carcinoma and is associated with tumor aggressiveness and postoperative recurrence.

Sun TW, Gao Q, Qiu SJ, Zhou J, Wang XY, Yi Y, Shi JY, Xu YF, Shi YH, Song K, Xiao YS, Fan J.

Cancer Immunol Immunother. 2012 Nov;61(11):2171-82. doi: 10.1007/s00262-012-1278-5. Epub 2012 May 22.

PMID:
22729558
13.

HIWI is associated with prognosis in patients with hepatocellular carcinoma after curative resection.

Zhao YM, Zhou JM, Wang LR, He HW, Wang XL, Tao ZH, Sun HC, Wu WZ, Fan J, Tang ZY, Wang L.

Cancer. 2012 May 15;118(10):2708-17. doi: 10.1002/cncr.26524. Epub 2011 Oct 11.

14.

Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.

Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S, Ren W.

J Clin Pathol. 2012 Sep;65(9):808-14. doi: 10.1136/jclinpath-2012-200721. Epub 2012 Jun 25.

PMID:
22734007
15.

Suppression of KIF3B expression inhibits human hepatocellular carcinoma proliferation.

Huang X, Liu F, Zhu C, Cai J, Wang H, Wang X, He S, Liu C, Yao L, Ding Z, Zhang Y, Zhang T.

Dig Dis Sci. 2014 Apr;59(4):795-806. doi: 10.1007/s10620-013-2969-2. Epub 2013 Dec 25.

16.

Expression and prognostic role of Spy1 as a novel cell cycle protein in hepatocellular carcinoma.

Ke Q, Ji J, Cheng C, Zhang Y, Lu M, Wang Y, Zhang L, Li P, Cui X, Chen L, He S, Shen A.

Exp Mol Pathol. 2009 Dec;87(3):167-72. doi: 10.1016/j.yexmp.2009.07.011. Epub 2009 Aug 15.

PMID:
19686732
17.

FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo.

Fang F, Yang L, Tao Y, Qin W.

Cancer. 2012 Jan 1;118(1):134-46. doi: 10.1002/cncr.26251. Epub 2011 Jun 28.

18.

Glycinamide ribonucleotide formyl transferase is frequently overexpressed in glioma and critically regulates the proliferation of glioma cells.

Liu X, Ding Z, Liu Y, Zhang J, Liu F, Wang X, He X, Cui G, Wang D.

Pathol Res Pract. 2014 Apr;210(4):256-63. doi: 10.1016/j.prp.2013.10.009. Epub 2013 Nov 15.

PMID:
24444710
19.

CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.

Chen B, Shen S, Wu J, Hua Y, Kuang M, Li S, Peng B.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):13725-38. eCollection 2015.

20.

Decreased expression of SOX6 confers a poor prognosis in hepatocellular carcinoma.

Guo X, Yang M, Gu H, Zhao J, Zou L.

Cancer Epidemiol. 2013 Oct;37(5):732-6. doi: 10.1016/j.canep.2013.05.002. Epub 2013 Jun 1.

PMID:
23731550

Supplemental Content

Support Center